Research progress on the association between glycemic variability index derived from CGM and cardiovascular disease

Lei Zhang1,2, Xiao-Xuan Sun3,4, Qing-Shan Tian5

  • 1The 1st Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, 330000, China.

Acta Diabetologica
|March 12, 2024
PubMed

Insights

Continuous glucose monitoring (CGM) offers superior insights into diabetes glycemic control over HbA1c. CGM parameters like time in range are linked to cardiovascular disease complications, guiding better patient care.

Area of Science:

  • Endocrinology
  • Cardiology
  • Metabolic Diseases

Background:

  • Glycated hemoglobin A1c (HbA1c) is a standard but limited measure of diabetes glycemic control.
  • Continuous glucose monitoring (CGM) provides detailed, real-time glycemic data.
  • Emerging CGM metrics like time in range (TIR), time above range (TAR), and time below range (TBR) offer new insights into glycemic variability.

Purpose of the Study:

  • To comprehensively review the association between CGM-derived glycemic parameters and cardiovascular disease (CVD) complications.
  • To provide scientific evidence for the standardized clinical application of CGM metrics.
  • To guide better glycemic control strategies for preventing CVD in diabetes patients.

Main Methods:

  • Systematic literature review of domestic and international studies.
  • Analysis of research linking CGM parameters (TIR, TAR, TBR) to CVD complications.
  • Evaluation of clinical data on glycemic fluctuation and patient outcomes.

Main Results:

  • CGM-derived glycemic parameters are significantly associated with microvascular and macrovascular complications of diabetes.
  • These metrics correlate with cardiovascular disease complications and prognosis.
  • CGM data offers a more nuanced understanding of glycemic control than HbA1c alone.

Conclusions:

  • CGM parameters are valuable indicators for assessing glycemic control and predicting CVD risk in diabetes.
  • Standardized use of CGM metrics can improve clinical decision-making and patient outcomes.
  • Further research and clinical integration of CGM are crucial for diabetes management and CVD prevention.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K
Overview of Carbohydrate Metabolism01:19

Overview of Carbohydrate Metabolism

Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
1.0K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
534
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
13.4K